SciSight Ecosystem
WoS SCIE Q4Scopus Q3SCImago #18,466CAS 4区Subscription

Nephrologie & Therapeutique

Abbreviation (ISO):NEPHROL THER
Country: France•WoS SCIE Quartile: Q4•Scopus SJR: 0.267•SCImago Rank: #18,466•Identifier (ISSN):1769-7255(Print)/1872-9177(Online)•Articles / Year: 77•Estimated Publication Fee (APC): $2,546 USD
Clarivate IF (2026)Q4
0.8
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
24

24 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate28.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
77articles/year
0% Gold OA•86.73% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 0.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 0.8)
🔵 Computed
20251.00đ
WoS Q4(IF: 0.7)
🔵 Computed
20241.00đ
WoS Q4(IF: 0.7)
🔵 Computed
20231.00đ
WoS Q4(IF: 0.7)
🔵 Computed
20221.00đ
WoS Q4(IF: 0.5)
🔵 Computed
20211.00đ
WoS Q4(IF: 0.722)
🔵 Computed
20201.00đ
WoS Q4(IF: 0.639)
🔵 Computed
20191.00đ
WoS Q4(IF: 0.812)
🔵 Computed
20181.00đ
WoS Q4(IF: 0.479)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Organe d'expression de la Société de Néphrologie, de la Société Francophone de Dialyse et de la Société de Néphrologie Pédiatrique, Néphrologie et Thérapeutique a pour vocation de publier des textes en français dans le domaine de la Néphrologie, qu'il s'agisse d'actualisation des connaissances, de recommandations de bonne pratique clinique, de publications originales, ou d'informations sur la vie des trois sociétés fondatrices. La variété des thèmes abordés reflète la richesse de la Néphrologie, qu'il s'agisse d'aspects fondamentaux issus de la physiologie, de l'immunologie, de l'anatomo-pathologie, ou de la génétique, ou de sujets de néphrologie clinique, notamment ceux en rapport avec les thérapeutiques néphrologiques, transplantation, hémodialyse et dialyse péritonéale.

Topics Covered (Recognized by AI)
Medicine98.2%Gynecology58.8%Internal medicine31.4%Biology25.9%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,466Scopus Q3SCImago Profile
Scopus Coverage:2005-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.267

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
31

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
0.55

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,546 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations119
3-Year Documents208
Citable Documents198

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

NephrologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区UROLOGY & NEPHROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
11.9周
Average time to first editorial decision
Online Publication Speed
20.6周
Time from acceptance to online publication
Official Acceptance Rate
37%
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Subscription
OA publishing option or traditional subscription
Publisher
Elsevier Masson
Publication Language
French
Frequency
Bimonthly
Founding Year
2005
Editorial Address
ELSEVIER MASSON, VIA PALEOCAPA 7, MILANO, ITALY, 20121
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
UROLOGY & NEPHROLOGY
JCRSCIE
116/134Q4
UROLOGY & NEPHROLOGY
JCISCIE
120/134Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—261
20250.75516
20240.74928
20230.75699
20220.5499245
20210.722432511
20200.639275230
20190.812411341
20180.479474471
2017—466916
2016—471640
2015—548455
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Nephrologie & Therapeutique

WoS Q4
0011201820192020202120222023202420250.70
Annual Impact Factor Metric
2025:0.7

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 28.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2ed4a25e-3102-47ee-9f51-927b498547c8
Database Updated: 2026-09-30